| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-17 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-13 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.33 | 6e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |